In this episode, Karl Friston (director of the Max Planck Institute for Human Cognitive and Brain Sciences) discusses the animal model of degenerative disease and its relevance to human pathology. He talks about the use of rodent models to study chemotherapeutics, and highlights some of the pitfalls of this research.